Esopam Drug Interactions

Avoid concomitant use of escitalopram with: Bromopride, Citalopram, Dapoxetine, Fexinidazole [INT], Linezolid, Methylene Blue, Monoamine Oxidase Inhibitors (Antidepressant), Pimozide, Rasagiline, Selegiline, Urokinase.
Escitalopram may increase the levels/effects of: Agents with Antiplatelet Properties, Anticoagulants, Antipsychotic Agents, Apixaban, Aripiprazole, Aspirin, Bemiparin, Blood Glucose Lowering Agents, Brexanolone, Cephalothin, Citalopram, Collagenase (Systemic), Dabigatran Etexilate, Deoxycholic Acid, Desmopressin, Domperidone, Doxepin-containing products, Duloxetine, Edoxaban, Enoxaparin, Gilteritinib, Haloperidol, Heparin, Ibritumomab Tiuxetan, Lofexidine, Methylene Blue, Monoamine Oxidase Inhibitors (Antidepressant), Nonsteroidal Anti-Inflammatory Agents (COX-2 selective), Nonsteroidal Anti-Inflammatory Agents (Nonselective), Obinutuzumab, Oxitriptan, Perhexiline, QT-prolonging Kinase inhibitors (Moderate Risk), QT-prolonging Miscellaneous Agents (Moderate Risk), QT-prolonging Moderate CYP3A4 Inhibitors (Moderate Risk), Rasagiline, Rivaroxaban, Salicylates, Selective Serotonin Reuptake Inhibitors, Selegiline, Serotonergic Non-Opioids CNS Depressants, Serotonin/Norepinephrine Reuptake Inhibitors, Thiazide and Thiazide-Like Diuretics, Thrombolytic Agents, Tricyclic Antidepressants, Urokinase, Vitamin K Antagonists.
The levels/effects of Escitalopram may be increased by: Acalabrutinib, Alcohol (Ethyl), Almotriptan, Alosetron, Amphetamines, Antiemetics (5HT3 Antagonists), Antipsychotic Agents, Bromopride, Bupropion, Buspirone, Cimetidine, Citalopram, CNS Depressants, Cyclobenzaprine, Dapoxetine, Dexmethylphenidate-Methylphenidate, Dextromethorphan, Eletriptan, Ergot Derivatives, Fat Emulsion (Fish Oil Based), Fexinidazole [INT], Glucosamine, Herbs, Anticoagulant/Antiplatelet Properties), Ibrutinib, Inotersen, Lasmiditan, Limaprost, Linezolid, Lofexidine, Lorcaserin, Metaxalone, Metoclopramide, Metyrosine, Multivitamins/Fluoride (with ADE), Multivitamins/Minerals (with ADEK, Folate, Iron), Multivitamins/Minerals (with AE, No Iron), Nefazodone, Nonsteroidal Anti-Inflammatory Agents (Topical), Omega-3 Fatty Acids, Omeprazole, Ondansetron, Opioid Agonists, Pentamidine (systemic), Pentosan Polysulfate Sodium, Pentoxifylline, Pimozide, Prostacyclin Analogues, QT-prolonging Agents (Highest Risk), QT-prolonging Antipsychotics (Moderate Risk), QT-prolonging Class IC Antiarrhythmics (Moderate Risk), QT-Prolonging Quinolones Antibiotics (Moderate Risk), QT-prolonging Strong CYP3A4 Inhibitors (Moderate Risk), Ramosetron, Safinamide, Serotonergic Agents (High Risk Miscellaneous), Serotonergic Opioids (High Risk), Serotonin 5-HT1D Receptor Agonists (Triptans), St. John's Wort, Syrian Rue, Tipranavir, Tramadol, Tricyclic Antidepressants, Vitamin E (Systemic), Vortioxetine, Zanubrutinib.
Escitalopram may decrease the levels/effects of: Ioflupane I 123, Simeprevir, Thyroid Products.
The levels/effects of Escitalopram may be decreased by: Bosentan, CYP2C19 Inducers (Moderate), CYP2C19 Inducers (Strong), CYP3A4 Inducers (Moderate), CYP3A4 Inducers (Strong), Cyproheptadine, Dabrafenib, Deferasirox, Enzalutamide, Erdafitinib, Gilteritinib, Lorlatinib, Mitotane, Nonsteroidal Anti-Inflammatory Agents (COX-2 selective), Nonsteroidal Anti-Inflammatory Agents (Nonselective), Sarilumab, Siltuximab, St. John's Wort, Tocilizumab.